Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios

Introduction: Drug resistance testing may improve the management of people living with HIV (PLWH) in several scenarios in low- and middle-income countries (LMICs). To guide assay development, the WHO published a target product profile (TPP) outlining two priority use cases (scenarios) for genotypic...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Robert W. Shafer, Kaiming Tao, Tom Loosli, Ana Abecasis, Daniele Armenia, George Bwire, Ricardo Sobhie Diaz, Joseph Fokam, Amalia Giron, Seth Inzaule, Rami Kantor, Cissy Kityo, Roger D. Kouyos, Swarali Kurle, Anne-Genevieve Marcelin, Roger Paredes, Martine Peeters, Victor F. Pimentel, Jonathan M. Schapiro, Kim Steegen, Marco Vitoria, Annemarie M. Wensing, Neil Parkin, Michael R. Jordan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2026-05-01
Цуврал:	Viruses
Нөхцлүүд:	Antiretroviral drugs HIV drug resistance HIV mutations
Онлайн хандалт:	https://www.mdpi.com/1999-4915/18/6/588
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!